# A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

> **NCT04651153** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 62 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** UCB7853
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04651153
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-14
- **Primary completion:** 2023-07-20
- **Final completion:** 2023-07-20
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651153, "A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04651153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*